Bruker (BRKR) Bank of America Global Healthcare Conference summary

Financial performance and outlook

• Organic order bookings and EPS outperformed in Q2, but revenue was delayed, with strong order growth in China and biopharma globally, while U.S. academic funding remained weak.

• Semi-metrology business saw remarkable growth driven by AI demand and advanced packaging, with order strength across most geographies except U.S. academia.

• High single-digit growth in diagnostics and strong performance in academic/government research outside the U.S.; Q3 expected push-outs in semi add to Q4 ramp.

• Q4 2026 revenue expected to exceed €1 billion, with volume leverage and cost-saving actions supporting operating margin expansion.

• 2027 outlook includes continued semi growth, biopharma recovery, and potential acceleration if industrial markets strengthen.

Market dynamics and funding environment

• U.S. academic/government research funding is showing signs of improvement, but order conversion to revenue will likely benefit 2027 more than 2026.

• Academic/government sector outside the U.S. (Europe, China, Korea, Japan) is performing well, with China showing stable and predictable funding.

• China’s ability to quickly pivot and fund targeted sectors is a key growth driver, offsetting U.S. funding delays.

• Biopharma and deep tech products are performing strongly in China and globally.

• U.S. academic/government market now represents about 8% of total revenue, down from previous years.

Semi-metrology and product portfolio

• Semi-metrology accounts for about 9% of revenue, with >15% order growth in Q2 and strong Q3 outlook; order conversion to revenue depends on customer fab timelines.

• Backlog remains high, with order timing subject to customer needs, but cancellations are rare; smoother revenue curve expected by 2027.

• Durable growth expected from flagship products like timsOmni (proteomics), timsMetabo (metabolites), and advanced microscopy and X-ray technologies.

• Annual R&D investment supports continuous innovation and market leadership in key segments.

• Expansion into energy fusion and security detection is expected to drive future growth.